Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 883 of 5804
-
Hair loss drug ritlecitinib tested for Long-Term safety in teens
Disease control Recruiting nowThe purpose of this clinical trial is to learn about long-term safety and long-term effects of the study medicine (called ritlecitinib) for the potential treatment of severe alopecia areata, a condition that causes hair loss. This study is seeking participants who have: * previ…
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Wrist device aims to zap PTSD nightmares and save hearts
Symptom relief Recruiting nowThe purpose of this study is to learn more about the effectiveness of a prescription wrist-wearable device called NightWare (NW) on improving sleep in Veterans with nightmares related to posttraumatic stress disorder (PTSD). The investigators also want to learn whether it improve…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 26, 2026 16:34 UTC
-
New drug combo aims to shrink liver tumors in colorectal cancer patients
Disease control Recruiting nowThis study will evaluate the safety and effectiveness of the combination of pembrolizumab and odetiglucan in patients with metastatic colorectal cancer that is predominantly in the liver.
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Fresh produce prescription aims to cut gestational diabetes in High-Risk moms
Prevention Not yet recruitingThe purpose of this study is to assess the effectiveness of a "Food is Medicine" (FIM) intervention on incidence of gestational diabetes mellitus (GDM) among pregnant women at risk for GDM within the Harris Health system.
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 26, 2026 16:03 UTC
-
Exercise after fear training boosts PTSD recovery in new study
Symptom relief Recruiting nowThe goal of the current project is to establish the efficacy and mechanisms of exercise-enhanced fear extinction retrieval and generalization in posttraumatic stress disorder (PTSD). Exposure therapy is the gold standard treatment for PTSD, yet is only associated with remission r…
Phase: NA • Sponsor: Josh Cisler • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New ablation technique tested against standard in heart failure patients
Disease control CompletedPatients with atrial fibrillation (AF) and heart failure with reduced left ventricular ejection fraction (HFrEF) are at particularly high cardiovascular risk. Rhythm-control by means of catheter-based pulmonary vein isolation (PVI) reduces all-cause mortality and rehospitalizatio…
Sponsor: St. Josefs-Hospital Wiesbaden GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a Viagra-Like drug slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingAlzheimer's disease is the most common cause of dementia in the elderly population. The disease is characterised by the presence of abnormal proteins in the brain, primarily β-amyloid (Aβ) and tau. Recent evidence suggests that Phosphodiesterase-5 (PDE-5) enzyme inhibitors may ho…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 26, 2026 17:17 UTC
-
New weekly shot aims to protect kidneys in obese patients
Disease control Recruiting nowThis multicenter, randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of UBT251 injection in obese/overweight chronic kidney disease (CKD) population
Phase: PHASE2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New Two-Drug combo could supercharge deworming in african kids
Prevention Recruiting nowAn open-label, randomized by school, two-arm pragmatic trial, will be conducted involving two study sites in Sub-Saharan-Africa (SSA), Ghana and Kenya, to evaluate safety and effectiveness of the newly developed fixed dose combination (FDC) of albendazole (ALB) and ivermectin (IV…
Phase: PHASE3 • Sponsor: Insud Pharma • Aim: Prevention
Last updated Jun 26, 2026 17:01 UTC
-
Breast cancer drug schedule showdown: continuous vs. intermittent dosing
Disease control Recruiting nowThis is a prospective, randomised, controlled, multicentre study to evaluate the efficacy and safety of continuous versus intermittent pyrotinib therapy in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer.
Phase: PHASE2 • Sponsor: Wenjin Yin • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Cold saline rinse after ERCP may prevent pancreatitis
Prevention CompletedEndoscopic retrograde cholangiopancreatography (ERCP) is an endoscopic procedure used to diagnose and treat problems in the bile ducts and pancreas. One of its most common complications is \*\*post-ERCP pancreatitis\*\*. This multicenter randomized clinical trial will evaluate wh…
Phase: PHASE2, PHASE3 • Sponsor: Universidad Nacional de Colombia • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Double antibiotic attack: could a Two-Drug combo beat severe infections faster?
Disease control Recruiting nowThe goal of this clinical trial is to : 1. Test whether the combination of CAZ±AVI and FOS leads to superior clinical outcomes in patients with severe suspected Gram-negative bacterial infection, as demonstrated by a shorter time to normalization of quick Sequential Organ Failur…
Phase: PHASE3 • Sponsor: Angela HUTTNER • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Stomach stitches for better sleep: new study tests weight loss procedure against sleep apnea
Disease control Recruiting nowStudy Overview: Obesity and Obstructive Sleep Apnea (OSA) are strongly linked. This study aims to understand whether a procedure called Endoscopic Sleeve Gastroplasty (ESG), along with lifestyle changes like healthy eating and regular exercise, can help improve symptoms of OSA i…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New shot shows promise for Long-Term control of bleeding disorder
Disease control Recruiting nowPrimary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a lower number of platelets, making it easier to bruise or bleed. The main aim of this study is to check how safe mez…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New diabetes pill HDM1002 enters final testing phase
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study, which aims to provide data on the efficacy and safety of HDM1002 tablets in adults with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise only
Phase: PHASE3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a malaria drug tame fatty liver? new trial aims to find out
Disease control Recruiting nowThe goal of this clinical trial is to learn if drug hydroxychloroquine works to treat steatohepatitis in adults. It will also learn about the safety of drug hydroxychloroquine. The main questions it aims to answer are: Does drug hydroxychloroquine improve steatohepatitis? What m…
Phase: PHASE3 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo aims to tackle Hard-to-Treat myeloma
Disease control Recruiting nowThe researchers are doing this study to find out whether combining teclistamab and mezigdomide is a safe and effective treatment approach in people with relapsed/refractory multiple myeloma (MM).
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New device zaps kidney nerves to tame stubborn high blood pressure
Disease control ENROLLING_BY_INVITATIONThis study is an observational one, collecting real-world data generated in routine clinical treatment. The Netrod-RDN renal artery radiofrequency ablation system (including the renal artery radiofrequency ablation device and the disposable mesh renal artery radiofrequency ablati…
Sponsor: Shanghai Golden Leaf MedTec Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Gene therapy SPOT-03 enters human testing for duchenne muscular dystrophy
Disease control Recruiting nowThe primary objective of this study is to evaluate the safety and tolerability of SPOT-03 administered by intravenous (IV) infusion to DMD patients. In addition, this study will preliminarily investigate the changes in dystrophin nucleic acid concentration, dystrophin protein exp…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Siponuoyin Biotechnology Co Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Brain cell transplant trial aims to restore movement in Parkinson's
Disease control Recruiting nowThis Phase I clinical trial is designed to evaluate the safety, tolerability of a single dose of XS411 (derived dopaminergic neural progenitor cell injection) in patients with primary Parkinson's disease
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:48 UTC